Skip to main content
Erschienen in: Clinical and Experimental Nephrology 3/2022

13.10.2021 | Original article

Cardio-ankle vascular index with renal progression and mortality in high atherosclerosis risk: a prospective cohort study in CORE-Thailand

verfasst von: Noppawit Aiumtrakul, Ouppatham Supasyndh, Rungroj Krittayaphong, Arintaya Phrommintikul, Bancha Satirapoj

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Increased arterial stiffness is linked to markers of endothelial dysfunction and vasculopathy such as albuminuria, vascular calcification, left ventricular hypertrophy and cardiovascular (CV) diseases. Studies of arterial stiffness on renal progression are limited.

Objective

The study aimed to evaluate the association between high cardio-ankle vascular index (CAVI) and renal endpoint and all-cause mortality in a Thai population with high atherosclerosis risk.

Methods

A multicenter prospective cohort study was conducted among subjects with high CV risk or established CV diseases in Thailand. Subjects were divided into 3 groups with mean CAVI < 8, 8–8.9, and ≥ 9, respectively. Primary composite outcome consisted of estimated glomerular filtration rate (eGFR) decline over 40%, eGFR less than 15 mL/min/1.73 m2, doubling of serum creatinine, initiation of dialysis and death related to renal causes. The secondary outcomes were all-cause mortality, CV mortality and eGFR decline.

Results

A total of 4898 subjects (2743 men and 2155 women) were enrolled. Cox proportional hazards model showed a significant relationship of high CAVI (CAVI ≥ 9) and primary composite outcome. Subjects with high CAVI at baseline had a 1.45-fold (95% CI 1.13–1.84) significant risk for the primary composite outcome and 1.72-fold (95% CI 1.12–2.63) risk for all-cause mortality, compared with normal CAVI (CAVI < 8). After stepwise multivariate analysis, the high CAVI group was only positively associated with primary composite outcome. Kaplan–Meier curve of the primary composite outcome and all-cause mortality demonstrated the worst survival in the high CAVI group (log-rank test with P < 0.05).

Conclusion

In a Thai cohort with high atherosclerosis risk, increased arterial stiffness was a risk factor for worsening renal function, including end-stage renal disease and initiation of dialysis.
Literatur
1.
Zurück zum Zitat Hidalgo-Santiago JC, Oneto-Otero J, Michan-Dona A, Gomez-Fernandez P. Role of increased central arterial stiffness in macro and microvascular damage in patients with coronary artery disease. Clin Investig Arterioscler. 2021;33(5):224–34.PubMed Hidalgo-Santiago JC, Oneto-Otero J, Michan-Dona A, Gomez-Fernandez P. Role of increased central arterial stiffness in macro and microvascular damage in patients with coronary artery disease. Clin Investig Arterioscler. 2021;33(5):224–34.PubMed
2.
Zurück zum Zitat Fitzpatrick J, Kim ED, Sozio SM, Jaar BG, Estrella MM, Monroy-Trujillo JM, et al. Calcification biomarkers, subclinical vascular disease, and mortality among multiethnic dialysis patients. Kidney Int Rep. 2020;5(10):1729–37.CrossRef Fitzpatrick J, Kim ED, Sozio SM, Jaar BG, Estrella MM, Monroy-Trujillo JM, et al. Calcification biomarkers, subclinical vascular disease, and mortality among multiethnic dialysis patients. Kidney Int Rep. 2020;5(10):1729–37.CrossRef
3.
Zurück zum Zitat Alonso-Dominguez R, Sanchez-Aguadero N, Patino-Alonso MC, Agudo-Conde C, de Cabo-Laso A, Gomez-Sanchez M, et al. Association between measurements of arterial stiffness and target organ damage in a general Spanish population. Ann Med. 2021;53(1):345–56.CrossRef Alonso-Dominguez R, Sanchez-Aguadero N, Patino-Alonso MC, Agudo-Conde C, de Cabo-Laso A, Gomez-Sanchez M, et al. Association between measurements of arterial stiffness and target organ damage in a general Spanish population. Ann Med. 2021;53(1):345–56.CrossRef
4.
Zurück zum Zitat Kendrick J, Chonchol MB. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nat Clin Pract Nephrol. 2008;4(12):672–81.CrossRef Kendrick J, Chonchol MB. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nat Clin Pract Nephrol. 2008;4(12):672–81.CrossRef
5.
Zurück zum Zitat Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011;26(4):379–85.CrossRef Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011;26(4):379–85.CrossRef
6.
Zurück zum Zitat Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–84.CrossRef Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–84.CrossRef
7.
Zurück zum Zitat Zhang C, Zhong Y, Tian H. Increased cardio-ankle vascular index is independently associated with chronic kidney disease: a cross-sectional study in Chinese patients with type 2 diabetes mellitus. J Diabetes Complicat. 2019;33(9):623–7.CrossRef Zhang C, Zhong Y, Tian H. Increased cardio-ankle vascular index is independently associated with chronic kidney disease: a cross-sectional study in Chinese patients with type 2 diabetes mellitus. J Diabetes Complicat. 2019;33(9):623–7.CrossRef
8.
Zurück zum Zitat Li K, Ferguson T, Embil J, Rigatto C, Komenda P, Tangri N. Risk of kidney failure, death, and cardiovascular events after lower limb complications in patients with CKD. Kidney Int Rep. 2021;6(2):381–8.CrossRef Li K, Ferguson T, Embil J, Rigatto C, Komenda P, Tangri N. Risk of kidney failure, death, and cardiovascular events after lower limb complications in patients with CKD. Kidney Int Rep. 2021;6(2):381–8.CrossRef
9.
Zurück zum Zitat Satirapoj B, Triwatana W, Supasyndh O. Arterial stiffness predicts rapid decline in glomerular filtration rate among patients with high cardiovascular risks. J Atheroscler Thromb. 2020;27(6):611–9.CrossRef Satirapoj B, Triwatana W, Supasyndh O. Arterial stiffness predicts rapid decline in glomerular filtration rate among patients with high cardiovascular risks. J Atheroscler Thromb. 2020;27(6):611–9.CrossRef
10.
Zurück zum Zitat Sun CK. Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness. Integr Blood Press Control. 2013;6:27–38.CrossRef Sun CK. Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness. Integr Blood Press Control. 2013;6:27–38.CrossRef
11.
Zurück zum Zitat Kim KJ, Lee BW, Kim HM, Shin JY, Kang ES, Cha BS, et al. Associations between cardio-ankle vascular index and microvascular complications in type 2 diabetes mellitus patients. J Atheroscler Thromb. 2011;18(4):328–36.CrossRef Kim KJ, Lee BW, Kim HM, Shin JY, Kang ES, Cha BS, et al. Associations between cardio-ankle vascular index and microvascular complications in type 2 diabetes mellitus patients. J Atheroscler Thromb. 2011;18(4):328–36.CrossRef
12.
Zurück zum Zitat Matsushita K, Ding N, Kim ED, Budoff M, Chirinos JA, Fernhall B, et al. Cardio-ankle vascular index and cardiovascular disease: Systematic review and meta-analysis of prospective and cross-sectional studies. J Clin Hypertens (Greenwich). 2019;21(1):16–24.CrossRef Matsushita K, Ding N, Kim ED, Budoff M, Chirinos JA, Fernhall B, et al. Cardio-ankle vascular index and cardiovascular disease: Systematic review and meta-analysis of prospective and cross-sectional studies. J Clin Hypertens (Greenwich). 2019;21(1):16–24.CrossRef
13.
Zurück zum Zitat Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age gene/environment susceptibility—Reykjavik study. Brain. 2011;134(Pt 11):3398–407.CrossRef Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age gene/environment susceptibility—Reykjavik study. Brain. 2011;134(Pt 11):3398–407.CrossRef
14.
Zurück zum Zitat Fesler P, Safar ME, du Cailar G, Ribstein J, Mimran A. Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. J Hypertens. 2007;25(9):1915–20.CrossRef Fesler P, Safar ME, du Cailar G, Ribstein J, Mimran A. Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. J Hypertens. 2007;25(9):1915–20.CrossRef
15.
Zurück zum Zitat Kim ED, Tanaka H, Ballew SH, Sang Y, Heiss G, Coresh J, et al. Associations between kidney disease measures and regional pulse wave velocity in a large community-based cohort: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2018;72(5):682–90.CrossRef Kim ED, Tanaka H, Ballew SH, Sang Y, Heiss G, Coresh J, et al. Associations between kidney disease measures and regional pulse wave velocity in a large community-based cohort: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2018;72(5):682–90.CrossRef
16.
Zurück zum Zitat Alizargar J, Bai CH, Hsieh NC, Wu SV, Weng SY, Wu JP. Association of kidney function tests with a cardio-ankle vascular index in community-dwelling individuals with a normal or mildly decreased estimated glomerular filtration rate. Medicina (Kaunas). 2019;55(10):657.CrossRef Alizargar J, Bai CH, Hsieh NC, Wu SV, Weng SY, Wu JP. Association of kidney function tests with a cardio-ankle vascular index in community-dwelling individuals with a normal or mildly decreased estimated glomerular filtration rate. Medicina (Kaunas). 2019;55(10):657.CrossRef
17.
Zurück zum Zitat Jeong JS, Kim JH, Kim DK, Oh KH, Joo KW, Kim YS, et al. Predictive value of cardio-ankle vascular index for the risk of end-stage renal disease. Clin Kidney J. 2021;14(1):255–60.CrossRef Jeong JS, Kim JH, Kim DK, Oh KH, Joo KW, Kim YS, et al. Predictive value of cardio-ankle vascular index for the risk of end-stage renal disease. Clin Kidney J. 2021;14(1):255–60.CrossRef
18.
Zurück zum Zitat Namikoshi T, Fujimoto S, Yorimitsu D, Ihoriya C, Fujimoto Y, Komai N, et al. Relationship between vascular function indexes, renal arteriolosclerosis, and renal clinical outcomes in chronic kidney disease. Nephrology (Carlton). 2015;20(9):585–90.CrossRef Namikoshi T, Fujimoto S, Yorimitsu D, Ihoriya C, Fujimoto Y, Komai N, et al. Relationship between vascular function indexes, renal arteriolosclerosis, and renal clinical outcomes in chronic kidney disease. Nephrology (Carlton). 2015;20(9):585–90.CrossRef
19.
Zurück zum Zitat Itano S, Yano Y, Nagasu H, Tomiyama H, Kanegae H, Makino H, et al. Association of arterial stiffness with kidney function among adults without chronic kidney disease. Am J Hypertens. 2020;33(11):1003–10.CrossRef Itano S, Yano Y, Nagasu H, Tomiyama H, Kanegae H, Makino H, et al. Association of arterial stiffness with kidney function among adults without chronic kidney disease. Am J Hypertens. 2020;33(11):1003–10.CrossRef
20.
Zurück zum Zitat Nakamura K, Iizuka T, Takahashi M, Shimizu K, Mikamo H, Nakagami T, et al. Association between cardio-ankle vascular index and serum cystatin C levels in patients with cardiovascular risk factor. J Atheroscler Thromb. 2009;16(4):371–9.CrossRef Nakamura K, Iizuka T, Takahashi M, Shimizu K, Mikamo H, Nakagami T, et al. Association between cardio-ankle vascular index and serum cystatin C levels in patients with cardiovascular risk factor. J Atheroscler Thromb. 2009;16(4):371–9.CrossRef
21.
Zurück zum Zitat Hitsumoto T. Correlation between the cardio-ankle vascular index and renal resistive index in patients with essential hypertension. Cardiol Res. 2020;11(2):106–12.CrossRef Hitsumoto T. Correlation between the cardio-ankle vascular index and renal resistive index in patients with essential hypertension. Cardiol Res. 2020;11(2):106–12.CrossRef
22.
Zurück zum Zitat Zuo J, Hu Y, Chang G, Chu SL, Tan I, Butlin M, et al. Relationship between arterial stiffness and chronic kidney disease in patients with primary hypertension. J Hum Hypertens. 2020;34(8):577–85.CrossRef Zuo J, Hu Y, Chang G, Chu SL, Tan I, Butlin M, et al. Relationship between arterial stiffness and chronic kidney disease in patients with primary hypertension. J Hum Hypertens. 2020;34(8):577–85.CrossRef
23.
Zurück zum Zitat Kim JM, Kim SS, Kim IJ, Kim JH, Kim BH, Kim MK, et al. Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study. Cardiovasc Diabetol. 2020;19(1):143.CrossRef Kim JM, Kim SS, Kim IJ, Kim JH, Kim BH, Kim MK, et al. Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study. Cardiovasc Diabetol. 2020;19(1):143.CrossRef
24.
Zurück zum Zitat Heinen Y, Stegemann E, Sansone R, Benedens K, Wagstaff R, Balzer J, et al. Local association between endothelial dysfunction and intimal hyperplasia: relevance in peripheral artery disease. J Am Heart Assoc. 2015;4(2):e001472.CrossRef Heinen Y, Stegemann E, Sansone R, Benedens K, Wagstaff R, Balzer J, et al. Local association between endothelial dysfunction and intimal hyperplasia: relevance in peripheral artery disease. J Am Heart Assoc. 2015;4(2):e001472.CrossRef
25.
Zurück zum Zitat Nowak KL, Jovanovich A, Farmer-Bailey H, Bispham N, Struemph T, Malaczewski M, et al. Vascular dysfunction, oxidative stress, and inflammation in chronic kidney disease. Kidney. 2020;1(6):501–9.CrossRef Nowak KL, Jovanovich A, Farmer-Bailey H, Bispham N, Struemph T, Malaczewski M, et al. Vascular dysfunction, oxidative stress, and inflammation in chronic kidney disease. Kidney. 2020;1(6):501–9.CrossRef
26.
Zurück zum Zitat Roumeliotis S, Mallamaci F, Zoccali C. Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update. J Clin Med. 2020;9(8):2359.CrossRef Roumeliotis S, Mallamaci F, Zoccali C. Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update. J Clin Med. 2020;9(8):2359.CrossRef
27.
Zurück zum Zitat Lim K, Lu TS, Molostvov G, Lee C, Lam FT, Zehnder D, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation. 2012;125(18):2243–55.CrossRef Lim K, Lu TS, Molostvov G, Lee C, Lam FT, Zehnder D, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation. 2012;125(18):2243–55.CrossRef
28.
Zurück zum Zitat Safar ME, Plante GE, Mimran A. Arterial stiffness, pulse pressure, and the kidney. Am J Hypertens. 2015;28(5):561–9.CrossRef Safar ME, Plante GE, Mimran A. Arterial stiffness, pulse pressure, and the kidney. Am J Hypertens. 2015;28(5):561–9.CrossRef
29.
Zurück zum Zitat Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int. 1987;31(5):1153–9.CrossRef Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int. 1987;31(5):1153–9.CrossRef
30.
Zurück zum Zitat Sequi-Dominguez I, Cavero-Redondo I, Alvarez-Bueno C, Pozuelo-Carrascosa DP, de Arenas-Arroyo SN, Martinez-Vizcaino V. Accuracy of pulse wave velocity predicting cardiovascular and all-cause mortality. A systematic review and meta-analysis. J Clin Med. 2020;9(7):2080.CrossRef Sequi-Dominguez I, Cavero-Redondo I, Alvarez-Bueno C, Pozuelo-Carrascosa DP, de Arenas-Arroyo SN, Martinez-Vizcaino V. Accuracy of pulse wave velocity predicting cardiovascular and all-cause mortality. A systematic review and meta-analysis. J Clin Med. 2020;9(7):2080.CrossRef
Metadaten
Titel
Cardio-ankle vascular index with renal progression and mortality in high atherosclerosis risk: a prospective cohort study in CORE-Thailand
verfasst von
Noppawit Aiumtrakul
Ouppatham Supasyndh
Rungroj Krittayaphong
Arintaya Phrommintikul
Bancha Satirapoj
Publikationsdatum
13.10.2021
Verlag
Springer Singapore
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2022
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-021-02149-x

Weitere Artikel der Ausgabe 3/2022

Clinical and Experimental Nephrology 3/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.